Home > Products > API > Hesperidin
Hesperidin
  • HesperidinHesperidin

Hesperidin

Product nomen: Hesperidin
Formulae hypotheticae: C28H34O15
M. Pondus; 610,56"
CAS Subcriptio Number: 520-26-3

Model:CAS NO:520-26-3

Mitte Inquisitionem

depictio producti

Hesperidin

Product nomen:Hesperidin 520-26-3
CAS No:520-26-3
Specification: in domo

Nomen Hesperidin
Synonyma (s) -7-[[6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy- IV-methoxyphenyl) -4h-I-benzopyran-IV-unum; HESPERID IN,HPLCWS-10001-(HD-0489)-200290%;HESPERIDINHEAVY92%BYHPLC;(S)-7-[[6-O-(6-Deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]oxyl. ]-2,3-dihydro-5-hydroxy-2-(Chemico) albook3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-unum;7-[6-O-(6-Deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyloxy]-2α-(3- hydroxy-4-methoxyphenyl)-5-hydroxy -2,3-dihydro-4H-1-benzopyran-4-one;Hesperidin,97%,includesanalogeous compositorum; Hesperidin,98%;
copyRight
M CAS # 59-02-9, Vitamin E, D-alpha-Tocopherol, (2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
Formulae hypotheticae C28H34O15
M. Pondus 610.56
CAS Subcriptio Number 520-26-3


Pertractatio et repono
Cautiones pro tutum pertractatio
Bene ventilatas tractantem in loco. Apta tutela vestitus. Pelle et oculis contactum fuge. Fuge formationem pulveris et aerosols. Utere instrumentis non-noctis. Ne ignis per electrostatic missionem vaporis.
Conditiones repono pro tuto, inter quaslibet incompatibilitates
Repone continens arcte clausum in loco sicco, frigido et bene ventilato. Disponunt a vasis victualibus vel materiae repugnantibus.

Imprimis usus finis (s): oeconomiae laboratoriae, ad investigationes scientificas et evolutionem tantum



Hot Tags: Hesperidin, China, Suppliers, Manufacturers, Factory
Related Categoria
Mitte Inquisitionem
Libenter placet, ut inquisitionem tuam in forma infra exhibeas. Respondebimus tibi in 24 horis.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept